Trial Profile
A Randomized, Active-Controlled, Open-label Clinical Trial to Evaluate the Safety and Efficacy of GAcarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes in Chinese
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary) ; Acarbose; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Nov 2015 New trial record